1. Home
  2. EXEL vs WES Comparison

EXEL vs WES Comparison

Compare EXEL & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exelixis Inc.

EXEL

Exelixis Inc.

N/A

Current Price

$65.20

Market Cap

17.8B

Sector

Health Care

ML Signal

N/A

Logo Western Midstream Partners LP

WES

Western Midstream Partners LP

N/A

Current Price

$40.12

Market Cap

17.3B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
EXEL
WES
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
17.8B
17.3B
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
EXEL
WES
Price
$65.20
$40.12
Analyst Decision
Buy
Buy
Analyst Count
17
15
Target Price
★ $61.36
$49.15
AVG Volume (30 Days)
★ 2.4M
1.7M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
★ 9.19%
EPS Growth
★ 57.95
N/A
EPS
★ 2.46
N/A
Revenue
$452,477,000.00
★ $3,843,403,000.00
Revenue This Year
$10.14
$23.74
Revenue Next Year
$12.56
$4.39
P/E Ratio
$26.76
★ $14.73
Revenue Growth
N/A
★ 6.61
52 Week Low
$39.71
$38.55
52 Week High
$73.69
$50.07

Technical Indicators

Market Signals
Indicator
EXEL
WES
Relative Strength Index (RSI) 45.48 32.87
Support Level $55.28 $39.98
Resistance Level $73.69 $42.84
Average True Range (ATR) 2.42 1.13
MACD -0.88 -0.08
Stochastic Oscillator 1.60 18.25

Price Performance

Historical Comparison
EXEL
WES

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About WES Western Midstream Partners LP

Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.

Share on Social Networks: